Jian You
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
Papers in
-
- Lung Cancer Diagnosis and Treatment 8
- Lung Cancer Treatments and Mutations 4
-
- Immunotherapy and Immune Responses 5
- Co-authors
- Xiubao Ren (6 shared papers)Yue Li (2 shared papers)Feng Wei (3 shared papers)Xiaoling Li (2 shared papers)Xishan Hao (2 shared papers)Zhenzhen Hui (4 shared papers)Changli Wang (6 shared papers)Yulong Chen (6 shared papers)
- Journals
- Translational Lung Cancer Research (3 papers)Journal of Controlled Release (3 papers)Journal of Surgical Research (2 papers)Signal Transduction and Targeted Therapy (1 paper)Journal of Thoracic Oncology (1 paper)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Jian You
38 papers receiving 964 citations
Jian You's Hit Papers
Peers
Comparison fields: 5 of 77
- Oncology 330
- Pulmonary and Respiratory Medicine 354
- Immunology 121
- Cancer Research 80
- Radiology, Nuclear Medicine and Imaging 70
Countries citing papers authored by Jian You
This map shows the geographic impact of Jian You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian You more than expected).
Fields of papers citing papers by Jian You
This network shows the impact of papers produced by Jian You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian You. The network helps show where Jian You may publish in the future.
Co-authors
The 25 scholars most cited alongside Jian You, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer Hit paper breakdown → | 2023 | 431 |
| 2 | 2019 | 73 | |
| 3 | 2022 | 49 | |
| 4 | 2019 | 47 | |
| 5 | 2024 | 44 | |
| 6 | 2012 | 39 | |
| 7 | 2023 | 36 | |
| 8 | 2013 | 31 | |
| 9 | 2013 | 26 | |
| 10 | 2021 | 26 | |
| 11 | 2022 | 19 | |
| 12 | 2023 | 15 | |
| 13 | 2014 | 14 | |
| 14 | 2016 | 14 | |
| 15 | 2014 | 13 | |
| 16 | 2020 | 13 | |
| 17 | 2022 | 13 | |
| 18 | 2023 | 12 | |
| 19 | 2008 | 11 | |
| 20 | 2022 | 6 |
About Jian You
Jian You is a scholar working on Pulmonary and Respiratory Medicine, Immunology, Oncology, Biotechnology and Radiology, Nuclear Medicine and Imaging, having authored 41 papers that have together received 985 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (8 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers), Lung Cancer Research Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer Research and Treatments (3 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Nanoplatforms for cancer theranostics (3 papers). The work is most often cited by research in Oncology (330 citations), Pulmonary and Respiratory Medicine (354 citations), Immunology (121 citations), Cancer Research (80 citations) and Radiology, Nuclear Medicine and Imaging (70 citations). Jian You has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Xiubao Ren, Yue Li, Feng Wei, Xiaoling Li, Xishan Hao, Zhenzhen Hui, Changli Wang, Yulong Chen, Wengui Xu and Ning Zhao. Their work appears in journals such as Translational Lung Cancer Research, Journal of Controlled Release, Journal of Surgical Research, Signal Transduction and Targeted Therapy and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.